Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Matthew L. Ulrickson"'
Autor:
Nirav N. Shah, Kwang Woo Ahn, Carlos Litovich, Timothy S. Fenske, Sairah Ahmed, Minoo Battiwalla, Nelli Bejanyan, Parastoo B. Dahi, Javier Bolaños-Meade, Andy I. Chen, Stefan O. Ciurea, Veronika Bachanova, Zachariah DeFilipp, Narendranath Epperla, Nosha Farhadfar, Alex F. Herrera, Bradley M. Haverkos, Leona Holmberg, Nasheed M. Hossain, Mohamed A. Kharfan-Dabaja, Vaishalee P. Kenkre, Hillard M. Lazarus, Hemant S. Murthy, Taiga Nishihori, Andrew R. Rezvani, Anita D'Souza, Bipin N. Savani, Matthew L. Ulrickson, Edmund K. Waller, Anna Sureda, Sonali M. Smith, Mehdi Hamadani
Publikováno v:
Blood Advances, Vol 2, Iss 8, Pp 933-940 (2018)
Abstract: The application of allogeneic hematopoietic cell transplantation (allo-HCT) in non-Hodgkin lymphoma (NHL) patients ≥65 years in the United States is limited by lack of Medicare coverage for this indication. Using the Center for Internatio
Externí odkaz:
https://doaj.org/article/e1f7f92829604e7783e85b8341e07274
Autor:
Jason R. Westin, Frederick L. Locke, Michael Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David B. Miklos, Matthew L. Ulrickson, Miguel-Angel Perales, Umar Farooq, Luciano Wannesson, Lori Leslie, Marie José Kersten, Caron A. Jacobson, John M. Pagel, Gerald Wulf, Patrick Johnston, Aaron P. Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia T. Snider, Paul Cheng, Christina To, Olalekan O. Oluwole, Anna Sureda
Publikováno v:
Clinical Cancer Research. 29:1894-1905
Purpose: Older patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) may be considered ineligible for curative-intent therapy including high-dose chemotherapy with autologous stem-cell transplantation (HDT-ASCT). Here, we report outcom
Autor:
Anna Sureda, Olalekan O. Oluwole, Christina To, Paul Cheng, Julia T. Snider, Jina Shah, Simone Filosto, Saran Vardhanabhuti, Linqiu Du, Aaron P. Rapoport, Patrick Johnston, Gerald Wulf, John M. Pagel, Caron A. Jacobson, Marie José Kersten, Lori Leslie, Luciano Wannesson, Umar Farooq, Miguel-Angel Perales, Matthew L. Ulrickson, David B. Miklos, Tom van Meerten, Mahmoud Elsawy, Armin Ghobadi, Michael Dickinson, Frederick L. Locke, Jason R. Westin
CAR T-cell levels in patients ≥65 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15d0cb50757effced27c720a6833dd16
https://doi.org/10.1158/1078-0432.22820212
https://doi.org/10.1158/1078-0432.22820212
Autor:
Charles Gaulin, Matthew L. Ulrickson, Muhammad Husnain, Madiha Iqbal, Paschalis Vergidis, Allison Rosenthal, Hemant Murthy, Carolyn Mead-Harvey, Yucai Wang, Januario E. Castro, Jeanne Palmer, Jose F. Leis, Patrick B. Johnston, Janis Blair, Mohamed A. Kharfan-Dabaja, Yi Lin, Javier Muñoz
Publikováno v:
Blood. 140:12111-12113
Autor:
Anna Sureda, Olalekan O. Oluwole, Christina To, Paul Cheng, Julia T. Snider, Jina Shah, Simone Filosto, Saran Vardhanabhuti, Linqiu Du, Aaron P. Rapoport, Patrick Johnston, Gerald Wulf, John M. Pagel, Caron A. Jacobson, Marie José Kersten, Lori Leslie, Luciano Wannesson, Umar Farooq, Miguel-Angel Perales, Matthew L. Ulrickson, David B. Miklos, Tom van Meerten, Mahmoud Elsawy, Armin Ghobadi, Michael Dickinson, Frederick L. Locke, Jason R. Westin
Tabulated data supporting ZUMA-7 elderly analysis Supplementary Table S1. Patient-reported outcomes instruments Supplementary Table S2. Axi-cel delivery and administration time Supplementary Table S3. Summary of efficacy and safety outcomes in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed1d9c15fc59705979f1ad8b7246a1d
https://doi.org/10.1158/1078-0432.22437814
https://doi.org/10.1158/1078-0432.22437814
Autor:
Anna Sureda, Olalekan O. Oluwole, Christina To, Paul Cheng, Julia T. Snider, Jina Shah, Simone Filosto, Saran Vardhanabhuti, Linqiu Du, Aaron P. Rapoport, Patrick Johnston, Gerald Wulf, John M. Pagel, Caron A. Jacobson, Marie José Kersten, Lori Leslie, Luciano Wannesson, Umar Farooq, Miguel-Angel Perales, Matthew L. Ulrickson, David B. Miklos, Tom van Meerten, Mahmoud Elsawy, Armin Ghobadi, Michael Dickinson, Frederick L. Locke, Jason R. Westin
Purpose:Older patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) may be considered ineligible for curative-intent therapy including high-dose chemotherapy with autologous stem-cell transplantation (HDT-ASCT). Here, we report outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99248bd428e15e0023b1de66dc79af07
https://doi.org/10.1158/1078-0432.c.6516061.v1
https://doi.org/10.1158/1078-0432.c.6516061.v1
Autor:
Sattva S. Neelapu, Michael Dickinson, Javier Munoz, Matthew L. Ulrickson, Catherine Thieblemont, Olalekan O. Oluwole, Alex F. Herrera, Chaitra S. Ujjani, Yi Lin, Peter A. Riedell, Natasha Kekre, Sven de Vos, Christine Lui, Francesca Milletti, Jinghui Dong, Hairong Xu, Julio C. Chavez
Publikováno v:
Nature Medicine. 28:735-742
High-risk large B-cell lymphoma (LBCL) has poor outcomes with standard first-line chemoimmunotherapy. In the phase 2, multicenter, single-arm ZUMA-12 study (ClinicalTrials.gov NCT03761056) we evaluated axicabtagene ciloleucel (axi-cel), an autologous
Autor:
Mahmoud Elsawy, Julio C. Chavez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob D. Rudzki, Saurabh Dahiya, Kathleen Dorritie, Samantha Jaglowski, John Radford, Franck Morschhauser, David Cunningham, Alejandro Martin Garcia-Sancho, Dimitrios Tzachanis, Matthew L. Ulrickson, Reem Karmali, Natasha Kekre, Catherine Thieblemont, Gunilla Enblad, Peter Dreger, Ram Malladi, Namita Joshi, Wei-Jhih Wang, Caitlyn T. Solem, Julia Thornton Snider, Paul Cheng, Christina To, Marie José Kersten
Publikováno v:
Blood, 140(21), 2248-2260. American Society of Hematology
Elsawy, M, Chavez, J C, Avivi, I, Larouche, J-F, Wannesson, L, Cwynarski, K, Osman, K, Davison, K, Rudzki, J D, Dahiya, S, Dorritie, K A, Jaglowski, S M, Radford, J, Morschhauser, F, Cunningham, D, Martin Garcia-Sancho, A, Tzachanis, D, Ulrickson, M L, Karmali, R, Kekre, N, Thieblemont, C, Enblad, G, Dreger, P, Malladi, R, Joshi, N, Wang, W-J, Solem, C T, Snider, J T, Cheng, P, To, C & Kersten, M J 2022, ' Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma ', Blood . https://doi.org/10.1182/blood.2022015478
Elsawy, M, Chavez, J C, Avivi, I, Larouche, J-F, Wannesson, L, Cwynarski, K, Osman, K, Davison, K, Rudzki, J D, Dahiya, S, Dorritie, K A, Jaglowski, S M, Radford, J, Morschhauser, F, Cunningham, D, Martin Garcia-Sancho, A, Tzachanis, D, Ulrickson, M L, Karmali, R, Kekre, N, Thieblemont, C, Enblad, G, Dreger, P, Malladi, R, Joshi, N, Wang, W-J, Solem, C T, Snider, J T, Cheng, P, To, C & Kersten, M J 2022, ' Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma ', Blood . https://doi.org/10.1182/blood.2022015478
Here, we report the first comparative analysis of patient-reported outcomes (PROs) with chimeric antigen receptor T-cell therapy vs standard-of-care (SOC) therapy in second-line relapsed/refractory large B-cell lymphoma (R/R LBCL) from the pivotal ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::461f94cf5a147a9b936b0e8596bcfa87
https://pure.amc.nl/en/publications/patientreported-outcomes-in-zuma7-a-phase-3-study-of-axicabtagene-ciloleucel-in-secondline-large-bcell-lymphoma(97d2d6dc-1bf2-4675-9ee8-a90efa10aa7d).html
https://pure.amc.nl/en/publications/patientreported-outcomes-in-zuma7-a-phase-3-study-of-axicabtagene-ciloleucel-in-secondline-large-bcell-lymphoma(97d2d6dc-1bf2-4675-9ee8-a90efa10aa7d).html
Autor:
Crystal Lee, Hayley Heers, Nicolas De Padova, Aileen Go, Murali K. Kodali, Matthew L. Ulrickson, Dr. Rajneesh Nath
Publikováno v:
Transplantation and Cellular Therapy. 29:S332-S333
Autor:
Nirav N. Shah, Richard T Maziarz, Caron A. Jacobson, Monalisa Ghosh, Iris Isufi, Matthew L. Ulrickson, Miguel-Angel Perales, Matthew Lunning, Dr. Nancy Maureen Hardy, Anna Wijatyk, Marek Ancukiewicz, Mrs. Madhavi Nallewar, Kimberly C. Coleman, Bethany Prudner, Esther Eromosele, Remi Kaleta, David B. Miklos
Publikováno v:
Transplantation and Cellular Therapy. 29:S13-S14